⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

TMO

Thermo Fisher Scientific Inc.

Healthcare · Diagnostics & Research

605.69USD

+2.6700 (+0.44%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 605.69
P/E32.1
Dvd Ind Yld0.3%
P/B4.25
P/S4.8
Curr EV/T12M EBITDA28.2
Mkt Cap (USD)224.0B
Curr EV (USD)262.6B
2)

Per Share Data

EPS T12M18.58
DPS1.78
Bk Val Per Sh142.47
Rev/Sh124.89
Cash/Sh10.99
Curr Shares Out369.7M
FCF/Sh19.73
3)

Cash Flow Analysis

P/CF24.8
Curr P/FCF30.6
CF/NI1.3
Dvd P/O9.5%
Cash Gen/Cash Reqd3.8
Csh Dvd Cov13.6
CFO/Sales19.5%
Eff Interest Rate3.5%
4)

Growth Potential

Dil EPS 1Y Gr7.3%
Cap 1Y Gr16.0%
BPS 1Y Gr9.1%
R&D To Sales3.0%
Retention Rate90.5%
Rev 1Y Gr3.9%
FCF 1Y Gr-13.4%
Assets 1Y Gr13.4%
5)

Profitability

EBITDA9.3B
EBIT8.1B
Operating Margin17.6%
Pretax Margin16.5%
Net Margin15.0%
ROA6.5%
ROE13.5%
ROC7.6%
Asset Turnover0.43
6)

Structure

Current Ratio1.55
Quick Ratio1.01
Debt/Assets40.3%
Debt/Com Eq86.7%
Net Debt/EBITDA4.47
Tot Debt/Capital46.4%
Gross Margin24.4%
EBIT/Int Exp5.6

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.